CBOE Q3 EPS Beats as Options Volume Momentum Persists; Valuation Remains Stretched

What happened

Cboe reported Q3 EPS of $3.63, beating the consensus estimate of $3.43 and up from $2.67 a year ago, with revenues also topping forecasts. The beat aligns with the strong derivatives volume trends highlighted in the latest 10-Q, where index options ADV grew 32% in Q2, but Q3 confirmation was a key checkpoint for the thesis. However, the earnings story remains predominantly volume-led rather than innovation-led, with the company's own disclosures showing total options market share slipping to 29.2% in Q4 2025 from 30.4% a year earlier. Expense control remains another critical variable; management reaffirmed 2026 adjusted operating expense guidance of $838-$853 million, but true cost discipline will only be proven if post-divestiture 2027 costs stay lean. At the pre-announcement price of $281 (21.8x earnings, 16.5x EV/EBITDA), the market already prices in sustained elevated volumes, and the Q3 beat does little to expand the margin of safety.

Implication

Cboe's Q3 earnings beat reflects continued strength in proprietary index options and 0DTE trading, reinforcing the structural volume growth narrative. Yet the stock trades near its base-case intrinsic value of $285, offering limited upside unless the bull scenario of persistent index-options growth and lean costs materializes. Investors should monitor subsequent monthly volume reports for any sequential cooling in index-options ADV, which would pressure the multiple. The pending sale of Cboe Australia and Canada, expected to close in Q3 2026, is a near-term catalyst that could provide a $300 million cash infusion but may also remove some revenue. Until Cboe demonstrates expense discipline beyond divestiture optics and discloses traction metrics for newer initiatives like Cboe Predicts, existing shareholders may hold, but new money should await a pullback toward $255-$260.

Thesis delta

The Q3 earnings beat is consistent with our WAIT thesis but does not change it. Strong volumes confirm the structural growth in index options, yet the valuation remains full at current levels. We continue to see limited margin of safety, and our re-assessment window of 3-6 months remains appropriate to evaluate volume sustainability and cost discipline.